arrow
W

Wei Cui

hebei university of engineering
H指数:23
被引数:1,980

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients

地西他滨联合氟达拉滨和环磷酰胺作为淋巴细胞耗竭方案,然后进行CD19/CD22双特异性靶向CAR T细胞治疗可显着改善复发/难治性b-all患者的生存率

2023-04-109
OAAI
Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell Transplantation
2021-06-0113
OAAI
CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

CD38-directed car-t细胞治疗: 异基因造血干细胞移植后复发急性髓系白血病的新型免疫治疗策略

2021-05-2581
OAAI